These patients also showed almost exclusive methylation of a putative transporter OSCP1. Abnormal methylation of a Src suppressor gene PDLIM4 was associated with shortened survival independently of CML stage and imatinib responsiveness. This evidence concerns the gene SRC and chronic myelogenous leukemia, BCR-ABL1 positive.